Discussion Of Identifying Profiles Of Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With A Long-Acting Injectable Antipsychotic
Mauricio Tohen, MD, DrPH, MBA; Joseph F. Goldberg, MD participated in a recent roundtable meeting, discussing the use of long-acting injectable antipsychotics in bipolar I disorder. In this follow-up recording Dr. Tohen and Dr. Goldberg review the use of long-acting injectable antipsychotics in bipolar I disorder and offer insight into recovery, nonadherence, and length of LAI antipsychotic treatment as well as consider how healthcare providers can discuss LAIs with their bipolar I patients.
Featuring:
Mauricio Tohen, MD, DrPH, MBAChairman of the Department …